Natto NSK Plus was created by a careful combination of the enzyme nattokinase, dihydromyricetin 98% and sodium ascorbate (vitamin C) in an acid-resistant capsule.
Fermented soy extract (NSK-SD) nattokinase has a strong effect:
- against the formation of deposits on the walls of blood vessels (thrombolytic effect).
- against the formation of fibrin deposits on the walls of blood vessels (fibrinolytic action).
- against the adhesion of blood cells, ie prevents the formation of blood clots, reduces blood density (antiplatelet effect) similar to acetylsalicylic acid (aspirin, andol, etc.), but after prolonged use there are no side effects.
- In atherosclerotic changes in blood vessels.
- Regulates cholesterol and triglycerides.
- Preventive and with therapy for stroke, heart attack, cardiovascular problems, varicose veins and all conditions of similar etiology.
- Prevents the danger of acute coronary syndrome, coronary atrophy of blood vessels.
History of natto
The Japanese have been using natto, a traditional Japanese dish of fermented black soy (an indigenous species), daily for centuries. In traditional medicine, natto is a delicacy that is good for health, especially for blood circulation and heart. Recent scientific studies have revealed why natto is good for health. The beneficial bacterium Bacillus subtilis natto produces fibrinolytic proteins (including nattokinase) during fermentation, which naturally help the body maintain optimal blood flow. That is why natto is an important food for those who want to reduce the risk of blood clots (thrombosis), which are the main factor in the development of cardiovascular diseases. Natto is a safe substitute for aspirin for healthy blood flow.
Unfortunately, the natto dish has an unpleasant taste, smell and texture. Outside of Japan, food is unavailable. Therefore, they have produced the enzyme nattokinase in Japan, which in the form of capsules or tablets can be used by users outside Japan and thus get all the benefits provided by consuming the enzyme nattokinase.
Dihydromyricetin (DHM), in addition to the general characteristics of flavonoids, is able to alleviate inflammation, reduce lipid consumption, increase cholesterol outflow and inhibit the formation of foam cells during atherosclerosis [https://www. /articles/10.3389/fphar.2018.01204/full]. DHM shows strong cardio protection in reperfusion injury of myocardial ischemia (I / R), adriamycin-induced cardiotoxicity, arrhythmia, myocardial remodeling, and pulmonary artery hypertension. DHM also lowers blood glucose, improves insulin resistance and reduces diabetic cardiomyopathy in diabetes. DHM protects against I / R liver injury, chemical liver injury, alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), and acute liver failure (ALF). In addition, DHM has been shown to protect against Alzheimer’s disease, Parkinson’s disease, and depressive disorder.
Sodium ascorbate, the most effective form of vitamin C, is one of the most important fighters against atherosclerosis. The leading killer in the world today is “heart disease” or “occlusive cardiovascular disease” – which is actually the scurvy of the modern age of the lower degree.
The disease is characterized by crustaceans that grow slowly on the walls of blood vessels. This process reduces the flow of blood to the heart and other organs, which leads to angina pectoris (heart spasm), heart attack and stroke.
The correct name for this process is “chronic scurvy”, a subclinical form of the classic disease of vitamin C deficiency.
The true nature of this disease was identified in the early 1950s by a Canadian team led by G. C. Willis, MD. This discovery was confirmed in the late 1980s by the then leading world scientist, Dr. Linus Pauling (1901-1994), a two-time Nobel Prize winner.
Canadian doctors have proven that vitamin C deficiency causes a disease known as “atherosclerosis”. They found that the disease occurs in 100% of animal experimental subjects who are deprived of vitamin C and who do not synthesize it themselves. Furthermore, they showed that vitamin C alone was sufficient to induce atherosclerosis in laboratory animals. (G.C. Willis, The Reversibility of Atherosclerosis, Canadian Medical Association Journal, vol. 77, June 15, 1957. pp. 106-109). The team conducted similar research on humans. The results showed a reduction in atherosclerotic plaque in human subjects.
Pauling informed the world about the importance of this problem through his lectures, written papers, and videos after he and his associates conducted experiments that confirmed Willis ’findings.
In a 1992 lecture, Dr. Linus Pauling explained why atherosclerosis develops on the walls of arteries in the absence of vitamin C in the form of the mineral sodium ascorbate. He explained how a specific form of cholesterol causes plaque, compensating for low amounts of vitamin C, and why his quick cure for chronic scurvy contains the amino acids proline and lysine.
* natto NSK Plus is compatible with anticoagulant drugs (eg. warfarin).
* natto NSK Plus does not contain genetically modified ingredients.
* natto NSK Plus increases the efficiency of the mechanisms of natural control (balance) of our body related to blood viscosity, without leading to excessive dilution of blood, unlike some drugs (acetylsalicylic acid).
* natto NSK Plus helps to restore the balance between clotting (coagulation) and the process of dissolving blood clots (thrombolysis and fibrinolysis) in the blood.